Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy.

Dhanya, R

Dhanya, R.

Affiliation

Dhanya R; Cardiovascular Diseases and Diabetes Biology Division, Rajiv Gandhi Centre for Biotechnology (RGCB), Thycaud Post, Poojappura, Trivandrum 695014, Kerala, India. Electronic address: dhanyarajendran@rgcb.res.in.

Biomed Pharmacother ; 146: 112560, 2022 Feb.

Article in En | MEDLINE | ID: mdl-34953390

Subject(s)

Diabetes Mellitus, Type 2/pathology; Hypoglycemic Agents/pharmacology; Quercetin/pharmacology; AMP-Activated Protein Kinases/drug effects; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/drug therapy; Glucose/metabolism; Glycation End Products, Advanced/drug effects; Humans; Hypoglycemic Agents/pharmacokinetics; Hypoglycemic Agents/therapeutic use; Insulin Resistance/physiology; Oxidative Stress/drug effects; Quercetin/pharmacokinetics; Quercetin/therapeutic use; Reactive Oxygen Species/metabolism; Signal Transduction/drug effects; TOR Serine-Threonine Kinases/drug effects

Key words

Diabetes; Hyperglycemia; Oxidative stress; Quercetin; Reactive oxygen species

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Quercetin / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Type of study: Prognostic_studies Language: En Journal: Biomed Pharmacother Year: 2022 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google